CIBC Private Wealth Group’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
13,689
-26
| -0.2% | -$2.71K | ﹤0.01% | 611 |
|
|
2025
Q1 | $1.34M | Sell |
13,715
-2,499
| -15% | -$244K | ﹤0.01% | 603 |
|
|
2024
Q4 | $1.34M | Hold |
16,214
| – | – | ﹤0.01% | 639 |
|
|
2024
Q3 | $1.46M | Hold |
16,214
| – | – | ﹤0.01% | 621 |
|
|
2024
Q2 | $1.36M | Sell |
16,214
-180
| -1% | -$15.1K | ﹤0.01% | 601 |
|
|
2024
Q1 | $1.26M | Sell |
16,394
-1,605
| -9% | -$124K | ﹤0.01% | 617 |
|
|
2023
Q4 | $1.43M | Buy |
17,999
+135
| +0.8% | +$10.7K | ﹤0.01% | 563 |
|
|
2023
Q3 | $1.25M | Sell |
17,864
-2,526
| -12% | -$177K | ﹤0.01% | 566 |
|
|
2023
Q2 | $1.47M | Buy |
20,390
+3,795
| +23% | +$273K | ﹤0.01% | 538 |
|
|
2023
Q1 | $1.02M | Sell |
16,595
-827
| -5% | -$51K | ﹤0.01% | 602 |
|
|
2022
Q4 | $1.34M | Sell |
17,422
-1,901
| -10% | -$147K | ﹤0.01% | 481 |
|
|
2022
Q3 | $862K | Sell |
19,323
-2,078
| -10% | -$92.7K | ﹤0.01% | 616 |
|
|
2022
Q2 | $820K | Buy |
21,401
+1,119
| +6% | +$42.9K | ﹤0.01% | 632 |
|
|
2022
Q1 | $839K | Hold |
20,282
| – | – | ﹤0.01% | 662 |
|
|
2021
Q4 | $766K | Buy |
20,282
+612
| +3% | +$23.1K | ﹤0.01% | 694 |
|
|
2021
Q3 | $648K | Hold |
19,670
| – | – | ﹤0.01% | 694 |
|
|
2021
Q2 | $1.33M | Hold |
19,670
| – | – | ﹤0.01% | 605 |
|
|
2021
Q1 | $1.11M | Buy |
19,670
+3,687
| +23% | +$209K | ﹤0.01% | 647 |
|
|
2020
Q4 | $1.3M | Buy |
15,983
+3,317
| +26% | +$270K | ﹤0.01% | 580 |
|
|
2020
Q3 | $902K | Buy |
+12,666
| New | +$902K | ﹤0.01% | 573 |
|